6533b7d9fe1ef96bd126c4a2
RESEARCH PRODUCT
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
S AlibertiGs CookBl BabuLf ReyesAh RodriguezF SanzNj SoniA AnzuetoP FaverioRf SadudI MuhammadC PratE VendrellJ NevesE KaimakamisA FeneleyR SwarnakarF FranzettiM CarugatiM MorosiE MongeMi RestrepoPk ArujS AttorriE BarimboimJp CaeiroMi GarzonVh CambursanoA CeccatoJ ChertcoffF LascarF Di TulioAc DiazL De VediaMc GanahaS LambertG LopardoV LopezCm LunaAg MalbertiN MorcilloS TartaraC PensottiB PereyraPg ScapellatoJp StagnaroS ShahF LotschF ThalhammerK AnseeuwCa FrancoisE Van BraeckelJl VincentMz DjimonJ BashiR DodoSa NouerP ChipevM EnchevaD MitevaD PetkovaAd BalkissouEwp YoneBhm NgahaneN ShenJf XuCab RicoR BuitragoFjp PaterninaJmk NtumbaVv CarevicM JakopovicM JankovicZ MatkovicI MitrecicMlb JacobssonAb ChristensenUch BodtgerCn MeyerAv JensenG Baunbaek-knudsenPt PetersenS AndersenIes Abd El-wahhabNe MorsyH ShafiekE SobhKa AbdulsemedF BertrandC Brun-buissonE De MontmollinM FartoukhJ MessikaP TattevinA KhouryB EbrukeM DreherM KolditzM MeisingerMw PletzS HagelJ RuppT SchabergM SpielmannsP CreutzN SuttorpB Siaw-larteyK DimakouD PapapetrouE TsigouD AmpazisM BhatiaR DharG D'souzaR GargPa KoulPa MaheshBs JayarajKv NarayanHb UdnurSb KrishnamurthyS KantS LimayeS SalviK GolshaniVm KeatingsI Martin-loechesY MaorJ StrahilevitzS BattagliaM CarrabbaP CerianaM ConfalonieriAd MonforteB Del PratoM De RosaR FantiniG FiorentinoMa GamminoF MenzellaG MilaniS NavaG PalmieroR PetrinoB GabrielliP RossiC SorinoG SteinhilberA ZanforlinM CaroneV PatellaS ScarlataA ComelK KurahashiZa BachaDb UgaldeOc ZunigaJf VillegasM MedenicaEmw Van De GardeDr MihsraP ShresthaE RidgeonBi AwokolaOno NwankwoAb OlufunlolaS OlumideKn UkwajaM IrfanL MinarowskiS SzymonF FroesP LeuschnerM MeirelesC FerraoSb RavaraV BrocovschiiC IonD RusuC TomaD ChiritaCm DorobatA BirkunA KaluzheninaA AlmotairiZaa BukharyJ EdathoduA FathyAma EnaniNe MohamedJu MemonA BellaN BogdanovicB MilenkovicD PesutL BorderiasNmb GarciaHc AlarconC CillonizA TorresV Diaz-britoX CasasAe GonzalezMl Fernandez-almiraM GallegoI Gaspar-garciaJg Del CastilloPj VictoriaEl MartinezRm De MolinaPj MarcosR MenendezA Pando-sandovalCp AymerichAl De La TorreI Garcia-oliveJ RelloS MoyanoO SibilaA Rodrigo-troyanoJ Sole-violanA UrangaJfm Van BovenEv TorraJa PujolC FeldmanHk YumAa FiogbeF YanguiS BilacerogluL DalarU YilmazA BogomolovN ElahiDj DhasmanaR IonsJ SkeemerG WoltmannC HancockAt HillB RudranS Ruiz-buitragoM CampbellP WhitakerA YouzguinA SinganayagamKs AllenV BritoJ DietzCe DysartSm KellieRa Franco-sadudG MeierM GagaTl HollandSp BerginF KheirM LandmeierM LoisGb NairH PatelK ReyesW Rodriguez-cintronS SaitoJ NodaCi HinojosaSm LevineLf AngelKs WhitlowJ HipskindK SukhijaV TottenRg WunderinkRd ShahKj MateyoL NoriegaE AlvaradoM AmanL Labrasubject
0301 basic medicineMaleStreptococcus pneumoniaantibiotic resistanceInternationalitysputum examinationbronchiectasisvery elderlyAntibioticsPrevalenceDrug resistancemedicine.disease_causeLogistic regressionGlobal HealthCommunity-Acquired Infections/epidemiologylung lavage0302 clinical medicineCommunity-acquired pneumoniaCost of IllnessRisk FactorsPrevalencedrug resistant Streptococcus pneumoniae pneumonia030212 general & internal medicineMicrobial drug resistantAged 80 and overadultinternational cooperationdrug effectMiddle Agedinfluenza vaccinationAnti-Bacterial Agentsantiinfective agentEuropeCommunity-Acquired InfectionsHospitalizationGlobal burden of diseaseStreptococcus pneumoniaeInfectious Diseasesrisk factorbacterium identificationFemalecommunity acquired infectioninfluenzaliver diseasepneumococcal vaccinationPneumococcal infectionhospitalizationmedicine.drugMicrobiology (medical)medicine.medical_specialtyAsiamedicine.drug_class030106 microbiologySettore MED/10 - Malattie Dell'Apparato RespiratorioArticleAnti-Bacterial Agents/pharmacology03 medical and health sciencesInternal medicineStreptococcus pneumoniaeDrug Resistance BacterialPneumonia Pneumococcal/epidemiologymedicineHumanscontrolled studyhumantetracyclineHospitalization/statistics & numerical dataAgedlevofloxacinnonhumanbusiness.industrydisease associationmicrobiologycommunity acquired pneumoniamacrolidePneumoniaasthmaSouth AmericaPneumonia Pneumococcalvaccinationmedicine.diseasemajor clinical studyantibiotic sensitivitypenicillin derivativePenicillinStreptococcus pneumoniae/drug effectsPneumoniablood examinationAfricaNorth Americamicrobiological examinationbusinessGlobal burden of disease; Microbial drug resistant; Pneumococcal infection; Pneumoniadescription
Objective: Streptococcus pneumoniae is the most frequent bacterial pathogen isolated in subjects with Community-acquired pneumonia (CAP) worldwide. Limited data are available regarding the current global burden and risk factors associated with drug-resistant Streptococcus pneumoniae (DRSP) in CAP subjects. We assessed the multinational prevalence and risk factors for DRSP-CAP in a multinational point-prevalence study. Design: The prevalence of DRSP-CAP was assessed by identification of DRSP in blood or respiratory samples among adults hospitalized with CAP in 54 countries. Prevalence and risk factors were compared among subjects that had microbiological testing and antibiotic susceptibility data. Multivariate logistic regressions were used to identify risk factors independently associated with DRSP-CAP. Results: 3,193 subjects were included in the study. The global prevalence of DRSP-CAP was 1.3% and continental prevalence rates were 7.0% in Africa, 1.2% in Asia, and 1.0% in South America, Europe, and North America, respectively. Macrolide resistance was most frequently identified in subjects with DRSP-CAP (0.6%) followed by penicillin resistance (0.5%). Subjects in Africa were more likely to have DRSP-CAP (OR: 7.6; 95% CI: 3.34-15.35, p < 0.001) when compared to centres representing other continents. Conclusions: This multinational point-prevalence study found a low global prevalence of DRSP-CAP that may impact guideline development and antimicrobial policies. Published by Elsevier Ltd on behalf of The British Infection Association.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2019-10-01 |